Pierpaolo Peruzzi, MD, PhD is an Assistant Professor and neurosurgeon at the Brigham and Women’s Hospital and Harvard Medical School. He attended medical school at University La Sapienza of Rome, in Italy, and received neurosurgery training, as well as a PhD in molecular biology, at the Ohio State University Medical Center, in Columbus, OH. Dr Peruzzi’s clinical practice is centered on the surgical care of patients affected by brain tumors, while his basic science laboratory focuses on the development of RNA-based therapies for glioblastoma. He is the principal investigator for a Phase 1 clinical trial studying the use of drug-releasing microdevices in patients with gliomas. As a resident, Dr Peruzzi was awarded the RUNN award by the Society of Neurological Surgeons, the NREF fellowship by the American Association of Neurological Surgeons, and was an R25 scholar. As a faculty, he has been awarded a K12 award by the NRCDP in 2016, a K08 Career Development Award from NINDS in 2017, and a R01 in 2020. He was the winner of the American Academy of Neurological Surgery Award in 2018, and the Harvard Medical School Dean’s Pilot grant for RNA in healthy aging in 2019. In 2020 he has received the Distinguished Scientist Award by the Sontag Foundation. Dr Peruzzi is a member of the Dana Farber Cancer Institute Scientific Review Committee, Faculty of the Harvard Initiative for RNA Medicine, and member of the Developmental Therapeutics study section at the NIH.